APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Nutritional Product

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Intravenous Nutritional Product Market Analysis and Forecast 2026-2032

29 December 2025201 pages

Choose your research edition.

Industry ResearchIntravenous Nutritional Product Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Nutritional Product Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Intravenous Nutritional Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Nutritional Product Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Nutritional Product Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Intravenous Nutritional Product market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Intravenous Nutritional Product is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Intravenous Nutritional Product is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Intravenous Nutritional Product is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Intravenous Nutritional Product is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Intravenous Nutritional Product include Xi'an Libang Pharmaceutical, Weixinkang, B. Braun, Baxter, Otsuka Pharmaceutical, Lummy, Lionco Pharmaceutical, King York and Kelun Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Intravenous Nutritional Product, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Intravenous Nutritional Product, also provides the revenue of main regions and countries. Of the upcoming market potential for Intravenous Nutritional Product, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intravenous Nutritional Product revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Intravenous Nutritional Product market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Intravenous Nutritional Product revenue, projected growth trends, production technology, application and end-user industry.

Intravenous Nutritional Product Segment by Company

Xi'an Libang Pharmaceutical

Weixinkang

B. Braun

Baxter

Otsuka Pharmaceutical

Lummy

Lionco Pharmaceutical

King York

Kelun Pharma

JW Pharmaceutical

Haisco Pharmaceutical Group

Grifols

Grand Life Sciences

Fresenius Kabi

Cisen

China Meheco Kangli

Biokin Pharmaceutical

BBCA Pharmaceutical

Baizheng Pharmaceutical

Aguettant

Intravenous Nutritional Product Segment by Type

Amino Acid

Alanyl-Glutamine

Heat and Fat Emulsion

Trace Elements

Vitamins

Intravenous Nutritional Product Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Others

Intravenous Nutritional Product Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Nutritional Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Nutritional Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Nutritional Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Intravenous Nutritional Product in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Intravenous Nutritional Product company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Nutritional Product revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Intravenous Nutritional Product Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Amino Acid Major Player Table 3. Alanyl-Glutamine Major Player Table 4. Heat and Fat Emulsion Major Player Table 5. Trace Elements Major Player Table 6. Vitamins Major Player Table 7. Global Intravenous Nutritional Product Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Pharmacies Major Player Table 9. Online Pharmacies Major Player Table 10. Retail Pharmacies Major Player Table 11. Others Major Player Table 12. Intravenous Nutritional Product Industry Trends Table 13. Intravenous Nutritional Product Industry Drivers Table 14. Intravenous Nutritional Product Industry Opportunities and Challenges Table 15. Intravenous Nutritional Product Industry Restraints Table 16. Global Intravenous Nutritional Product Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Intravenous Nutritional Product Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Intravenous Nutritional Product Market Share by Region (2021-2026) Table 19. Global Intravenous Nutritional Product Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Intravenous Nutritional Product Market Share by Region (2027-2032) Table 21. Global Intravenous Nutritional Product Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Intravenous Nutritional Product Revenue Market Share by Players (2021-2026) Table 23. Global Intravenous Nutritional Product Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Intravenous Nutritional Product Key Players Headquarters & Area Served Table 25. Global Intravenous Nutritional Product Players, Product Type & Application Table 26. Global Intravenous Nutritional Product Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Intravenous Nutritional Product by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Intravenous Nutritional Product Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Intravenous Nutritional Product Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Intravenous Nutritional Product Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Intravenous Nutritional Product Revenue Market Share by Type (2021-2026) Table 33. Global Intravenous Nutritional Product Revenue Market Share by Type (2027-2032) Table 34. Global Intravenous Nutritional Product Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Intravenous Nutritional Product Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Intravenous Nutritional Product Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Intravenous Nutritional Product Revenue Market Share by Application (2021-2026) Table 38. Global Intravenous Nutritional Product Revenue Market Share by Application (2027-2032) Table 39. Xi'an Libang Pharmaceutical Company Information Table 40. Xi'an Libang Pharmaceutical Business Overview Table 41. Xi'an Libang Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Xi'an Libang Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 43. Xi'an Libang Pharmaceutical Recent Development Table 44. Weixinkang Company Information Table 45. Weixinkang Business Overview Table 46. Weixinkang Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Weixinkang Intravenous Nutritional Product Product Portfolio Table 48. Weixinkang Recent Development Table 49. B. Braun Company Information Table 50. B. Braun Business Overview Table 51. B. Braun Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. B. Braun Intravenous Nutritional Product Product Portfolio Table 53. B. Braun Recent Development Table 54. Baxter Company Information Table 55. Baxter Business Overview Table 56. Baxter Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Baxter Intravenous Nutritional Product Product Portfolio Table 58. Baxter Recent Development Table 59. Otsuka Pharmaceutical Company Information Table 60. Otsuka Pharmaceutical Business Overview Table 61. Otsuka Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Otsuka Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 63. Otsuka Pharmaceutical Recent Development Table 64. Lummy Company Information Table 65. Lummy Business Overview Table 66. Lummy Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Lummy Intravenous Nutritional Product Product Portfolio Table 68. Lummy Recent Development Table 69. Lionco Pharmaceutical Company Information Table 70. Lionco Pharmaceutical Business Overview Table 71. Lionco Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Lionco Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 73. Lionco Pharmaceutical Recent Development Table 74. King York Company Information Table 75. King York Business Overview Table 76. King York Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. King York Intravenous Nutritional Product Product Portfolio Table 78. King York Recent Development Table 79. Kelun Pharma Company Information Table 80. Kelun Pharma Business Overview Table 81. Kelun Pharma Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Kelun Pharma Intravenous Nutritional Product Product Portfolio Table 83. Kelun Pharma Recent Development Table 84. JW Pharmaceutical Company Information Table 85. JW Pharmaceutical Business Overview Table 86. JW Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. JW Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 88. JW Pharmaceutical Recent Development Table 89. Haisco Pharmaceutical Group Company Information Table 90. Haisco Pharmaceutical Group Business Overview Table 91. Haisco Pharmaceutical Group Intravenous Nutritional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Haisco Pharmaceutical Group Intravenous Nutritional Product Product Portfolio Table 93. Haisco Pharmaceutical Group Recent Development Table 94. Grifols Company Information Table 95. Grifols Business Overview Table 96. Grifols Intravenous Nutritional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Grifols Intravenous Nutritional Product Product Portfolio Table 98. Grifols Recent Development Table 99. Grand Life Sciences Company Information Table 100. Grand Life Sciences Business Overview Table 101. Grand Life Sciences Intravenous Nutritional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Grand Life Sciences Intravenous Nutritional Product Product Portfolio Table 103. Grand Life Sciences Recent Development Table 104. Fresenius Kabi Company Information Table 105. Fresenius Kabi Business Overview Table 106. Fresenius Kabi Intravenous Nutritional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Fresenius Kabi Intravenous Nutritional Product Product Portfolio Table 108. Fresenius Kabi Recent Development Table 109. Cisen Company Information Table 110. Cisen Business Overview Table 111. Cisen Intravenous Nutritional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Cisen Intravenous Nutritional Product Product Portfolio Table 113. Cisen Recent Development Table 114. China Meheco Kangli Company Information Table 115. China Meheco Kangli Business Overview Table 116. China Meheco Kangli Intravenous Nutritional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. China Meheco Kangli Intravenous Nutritional Product Product Portfolio Table 118. China Meheco Kangli Recent Development Table 119. Biokin Pharmaceutical Company Information Table 120. Biokin Pharmaceutical Business Overview Table 121. Biokin Pharmaceutical Intravenous Nutritional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Biokin Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 123. Biokin Pharmaceutical Recent Development Table 124. BBCA Pharmaceutical Company Information Table 125. BBCA Pharmaceutical Business Overview Table 126. BBCA Pharmaceutical Intravenous Nutritional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. BBCA Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 128. BBCA Pharmaceutical Recent Development Table 129. Baizheng Pharmaceutical Company Information Table 130. Baizheng Pharmaceutical Business Overview Table 131. Baizheng Pharmaceutical Intravenous Nutritional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Baizheng Pharmaceutical Intravenous Nutritional Product Product Portfolio Table 133. Baizheng Pharmaceutical Recent Development Table 134. Aguettant Company Information Table 135. Aguettant Business Overview Table 136. Aguettant Intravenous Nutritional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Aguettant Intravenous Nutritional Product Product Portfolio Table 138. Aguettant Recent Development Table 139. North America Intravenous Nutritional Product Revenue by Type (2021-2026) & (US$ Million) Table 140. North America Intravenous Nutritional Product Revenue by Type (2027-2032) & (US$ Million) Table 141. North America Intravenous Nutritional Product Revenue by Application (2021-2026) & (US$ Million) Table 142. North America Intravenous Nutritional Product Revenue by Application (2027-2032) & (US$ Million) Table 143. North America Intravenous Nutritional Product Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. North America Intravenous Nutritional Product Revenue by Country (2021-2026) & (US$ Million) Table 145. North America Intravenous Nutritional Product Revenue by Country (US$ Million) & (2027-2032) Table 146. Europe Intravenous Nutritional Product Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Intravenous Nutritional Product Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Intravenous Nutritional Product Revenue by Application (2021-2026) & (US$ Million) Table 149. Europe Intravenous Nutritional Product Revenue by Application (2027-2032) & (US$ Million) Table 150. Europe Intravenous Nutritional Product Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Europe Intravenous Nutritional Product Revenue by Country (2021-2026) & (US$ Million) Table 152. Europe Intravenous Nutritional Product Revenue by Country (US$ Million) & (2027-2032) Table 153. China Intravenous Nutritional Product Revenue by Type (2021-2026) & (US$ Million) Table 154. China Intravenous Nutritional Product Revenue by Type (2027-2032) & (US$ Million) Table 155. China Intravenous Nutritional Product Revenue by Application (2021-2026) & (US$ Million) Table 156. China Intravenous Nutritional Product Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Intravenous Nutritional Product Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Intravenous Nutritional Product Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Intravenous Nutritional Product Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia Intravenous Nutritional Product Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Intravenous Nutritional Product Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Asia Intravenous Nutritional Product Revenue by Region (US$ Million) & (2021-2026) Table 163. Asia Intravenous Nutritional Product Revenue by Region (US$ Million) & (2027-2032) Table 164. SAMEA Intravenous Nutritional Product Revenue by Type (2021-2026) & (US$ Million) Table 165. SAMEA Intravenous Nutritional Product Revenue by Type (2027-2032) & (US$ Million) Table 166. SAMEA Intravenous Nutritional Product Revenue by Application (2021-2026) & (US$ Million) Table 167. SAMEA Intravenous Nutritional Product Revenue by Application (2027-2032) & (US$ Million) Table 168. SAMEA Intravenous Nutritional Product Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. SAMEA Intravenous Nutritional Product Revenue by Country (2021-2026) & (US$ Million) Table 170. SAMEA Intravenous Nutritional Product Revenue by Country (US$ Million) & (2027-2032) Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Intravenous Nutritional Product Image Figure 2. Global Intravenous Nutritional Product Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Nutritional Product Market Size Share 2021 VS 2025 VS 2032 Figure 4. Amino Acid Image Figure 5. Alanyl-Glutamine Image Figure 6. Heat and Fat Emulsion Image Figure 7. Trace Elements Image Figure 8. Vitamins Image Figure 9. Global Intravenous Nutritional Product Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Intravenous Nutritional Product Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Pharmacies Image Figure 12. Online Pharmacies Image Figure 13. Retail Pharmacies Image Figure 14. Others Image Figure 15. Global Intravenous Nutritional Product Market Size (US$ Million) & (2021-2032) Figure 16. Global Intravenous Nutritional Product Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Intravenous Nutritional Product Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Intravenous Nutritional Product Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Intravenous Nutritional Product Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Intravenous Nutritional Product Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Intravenous Nutritional Product Revenue Market Share by Type (2021-2032) Figure 23. Global Intravenous Nutritional Product Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Intravenous Nutritional Product Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Intravenous Nutritional Product Revenue Market Share by Application (2021-2032) Figure 26. North America Intravenous Nutritional Product Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Intravenous Nutritional Product Revenue Share by Type (2021-2032) Figure 28. North America Intravenous Nutritional Product Revenue Share by Application (2021-2032) Figure 29. North America Intravenous Nutritional Product Revenue Share by Country (2021-2032) Figure 30. United States Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Intravenous Nutritional Product Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Intravenous Nutritional Product Revenue Share by Type (2021-2032) Figure 35. Europe Intravenous Nutritional Product Revenue Share by Application (2021-2032) Figure 36. Europe Intravenous Nutritional Product Revenue Share by Country (2021-2032) Figure 37. Germany Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Intravenous Nutritional Product Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Intravenous Nutritional Product Revenue Share by Type (2021-2032) Figure 47. China Intravenous Nutritional Product Revenue Share by Application (2021-2032) Figure 48. Asia Intravenous Nutritional Product Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Intravenous Nutritional Product Revenue Share by Type (2021-2032) Figure 50. Asia Intravenous Nutritional Product Revenue Share by Application (2021-2032) Figure 51. Asia Intravenous Nutritional Product Revenue Share by Region (2021-2032) Figure 52. Japan Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Intravenous Nutritional Product Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Intravenous Nutritional Product Revenue Share by Type (2021-2032) Figure 60. SAMEA Intravenous Nutritional Product Revenue Share by Application (2021-2032) Figure 61. SAMEA Intravenous Nutritional Product Revenue Share by Country (2021-2032) Figure 62. Brazil Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Intravenous Nutritional Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Amino Acid
  • Alanyl-Glutamine
  • Heat and Fat Emulsion
  • Trace Elements
  • Vitamins
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Xi'an Libang Pharmaceutical
  • Weixinkang
  • B. Braun
  • Baxter
  • Otsuka Pharmaceutical
  • Lummy
  • Lionco Pharmaceutical
  • King York
  • Kelun Pharma
  • JW Pharmaceutical
  • Haisco Pharmaceutical Group
  • Grifols
  • Grand Life Sciences
  • Fresenius Kabi
  • Cisen
  • China Meheco Kangli
  • Biokin Pharmaceutical
  • BBCA Pharmaceutical
  • Baizheng Pharmaceutical
  • Aguettant

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Intravenous Nutritional Product Market by Type
  3. 1.2.1 Global Intravenous Nutritional Product Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Amino Acid
  5. 1.2.3 Alanyl-Glutamine
  6. 1.2.4 Heat and Fat Emulsion
  7. 1.2.5 Trace Elements
  8. 1.2.6 Vitamins
  9. 1.3 Intravenous Nutritional Product Market by Application
  10. 1.3.1 Global Intravenous Nutritional Product Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital Pharmacies
  12. 1.3.3 Online Pharmacies
  13. 1.3.4 Retail Pharmacies
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Intravenous Nutritional Product Market Dynamics
  1. 2.1 Intravenous Nutritional Product Industry Trends
  2. 2.2 Intravenous Nutritional Product Industry Drivers
  3. 2.3 Intravenous Nutritional Product Industry Opportunities and Challenges
  4. 2.4 Intravenous Nutritional Product Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Intravenous Nutritional Product Market Perspective (2021-2032)
  2. 3.2 Global Intravenous Nutritional Product Growth Trends by Region
  3. 3.2.1 Global Intravenous Nutritional Product Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Intravenous Nutritional Product Market Size by Region (2021-2026)
  5. 3.2.3 Global Intravenous Nutritional Product Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Intravenous Nutritional Product Revenue by Players
  2. 4.1.1 Global Intravenous Nutritional Product Revenue by Players (2021-2026)
  3. 4.1.2 Global Intravenous Nutritional Product Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Intravenous Nutritional Product Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Intravenous Nutritional Product Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Intravenous Nutritional Product Key Players Headquarters & Area Served
  7. 4.4 Global Intravenous Nutritional Product Players, Product Type & Application
  8. 4.5 Global Intravenous Nutritional Product Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Intravenous Nutritional Product Market CR5 and HHI
  11. 4.6.3 2025 Intravenous Nutritional Product Tier 1, Tier 2, and Tier 3
5 Intravenous Nutritional Product Market Size by Type
  1. 5.1 Global Intravenous Nutritional Product Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Intravenous Nutritional Product Revenue by Type (2021-2032)
  3. 5.3 Global Intravenous Nutritional Product Revenue Market Share by Type (2021-2032)
6 Intravenous Nutritional Product Market Size by Application
  1. 6.1 Global Intravenous Nutritional Product Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Intravenous Nutritional Product Revenue by Application (2021-2032)
  3. 6.3 Global Intravenous Nutritional Product Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Xi'an Libang Pharmaceutical
  2. 7.1.1 Xi'an Libang Pharmaceutical Company Information
  3. 7.1.2 Xi'an Libang Pharmaceutical Business Overview
  4. 7.1.3 Xi'an Libang Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Xi'an Libang Pharmaceutical Intravenous Nutritional Product Product Portfolio
  6. 7.1.5 Xi'an Libang Pharmaceutical Recent Developments
  7. 7.2 Weixinkang
  8. 7.2.1 Weixinkang Company Information
  9. 7.2.2 Weixinkang Business Overview
  10. 7.2.3 Weixinkang Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Weixinkang Intravenous Nutritional Product Product Portfolio
  12. 7.2.5 Weixinkang Recent Developments
  13. 7.3 B. Braun
  14. 7.3.1 B. Braun Company Information
  15. 7.3.2 B. Braun Business Overview
  16. 7.3.3 B. Braun Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  17. 7.3.4 B. Braun Intravenous Nutritional Product Product Portfolio
  18. 7.3.5 B. Braun Recent Developments
  19. 7.4 Baxter
  20. 7.4.1 Baxter Company Information
  21. 7.4.2 Baxter Business Overview
  22. 7.4.3 Baxter Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Baxter Intravenous Nutritional Product Product Portfolio
  24. 7.4.5 Baxter Recent Developments
  25. 7.5 Otsuka Pharmaceutical
  26. 7.5.1 Otsuka Pharmaceutical Company Information
  27. 7.5.2 Otsuka Pharmaceutical Business Overview
  28. 7.5.3 Otsuka Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Otsuka Pharmaceutical Intravenous Nutritional Product Product Portfolio
  30. 7.5.5 Otsuka Pharmaceutical Recent Developments
  31. 7.6 Lummy
  32. 7.6.1 Lummy Company Information
  33. 7.6.2 Lummy Business Overview
  34. 7.6.3 Lummy Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Lummy Intravenous Nutritional Product Product Portfolio
  36. 7.6.5 Lummy Recent Developments
  37. 7.7 Lionco Pharmaceutical
  38. 7.7.1 Lionco Pharmaceutical Company Information
  39. 7.7.2 Lionco Pharmaceutical Business Overview
  40. 7.7.3 Lionco Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Lionco Pharmaceutical Intravenous Nutritional Product Product Portfolio
  42. 7.7.5 Lionco Pharmaceutical Recent Developments
  43. 7.8 King York
  44. 7.8.1 King York Company Information
  45. 7.8.2 King York Business Overview
  46. 7.8.3 King York Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  47. 7.8.4 King York Intravenous Nutritional Product Product Portfolio
  48. 7.8.5 King York Recent Developments
  49. 7.9 Kelun Pharma
  50. 7.9.1 Kelun Pharma Company Information
  51. 7.9.2 Kelun Pharma Business Overview
  52. 7.9.3 Kelun Pharma Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Kelun Pharma Intravenous Nutritional Product Product Portfolio
  54. 7.9.5 Kelun Pharma Recent Developments
  55. 7.10 JW Pharmaceutical
  56. 7.10.1 JW Pharmaceutical Company Information
  57. 7.10.2 JW Pharmaceutical Business Overview
  58. 7.10.3 JW Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  59. 7.10.4 JW Pharmaceutical Intravenous Nutritional Product Product Portfolio
  60. 7.10.5 JW Pharmaceutical Recent Developments
  61. 7.11 Haisco Pharmaceutical Group
  62. 7.11.1 Haisco Pharmaceutical Group Company Information
  63. 7.11.2 Haisco Pharmaceutical Group Business Overview
  64. 7.11.3 Haisco Pharmaceutical Group Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Haisco Pharmaceutical Group Intravenous Nutritional Product Product Portfolio
  66. 7.11.5 Haisco Pharmaceutical Group Recent Developments
  67. 7.12 Grifols
  68. 7.12.1 Grifols Company Information
  69. 7.12.2 Grifols Business Overview
  70. 7.12.3 Grifols Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Grifols Intravenous Nutritional Product Product Portfolio
  72. 7.12.5 Grifols Recent Developments
  73. 7.13 Grand Life Sciences
  74. 7.13.1 Grand Life Sciences Company Information
  75. 7.13.2 Grand Life Sciences Business Overview
  76. 7.13.3 Grand Life Sciences Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Grand Life Sciences Intravenous Nutritional Product Product Portfolio
  78. 7.13.5 Grand Life Sciences Recent Developments
  79. 7.14 Fresenius Kabi
  80. 7.14.1 Fresenius Kabi Company Information
  81. 7.14.2 Fresenius Kabi Business Overview
  82. 7.14.3 Fresenius Kabi Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Fresenius Kabi Intravenous Nutritional Product Product Portfolio
  84. 7.14.5 Fresenius Kabi Recent Developments
  85. 7.15 Cisen
  86. 7.15.1 Cisen Company Information
  87. 7.15.2 Cisen Business Overview
  88. 7.15.3 Cisen Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Cisen Intravenous Nutritional Product Product Portfolio
  90. 7.15.5 Cisen Recent Developments
  91. 7.16 China Meheco Kangli
  92. 7.16.1 China Meheco Kangli Company Information
  93. 7.16.2 China Meheco Kangli Business Overview
  94. 7.16.3 China Meheco Kangli Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  95. 7.16.4 China Meheco Kangli Intravenous Nutritional Product Product Portfolio
  96. 7.16.5 China Meheco Kangli Recent Developments
  97. 7.17 Biokin Pharmaceutical
  98. 7.17.1 Biokin Pharmaceutical Company Information
  99. 7.17.2 Biokin Pharmaceutical Business Overview
  100. 7.17.3 Biokin Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Biokin Pharmaceutical Intravenous Nutritional Product Product Portfolio
  102. 7.17.5 Biokin Pharmaceutical Recent Developments
  103. 7.18 BBCA Pharmaceutical
  104. 7.18.1 BBCA Pharmaceutical Company Information
  105. 7.18.2 BBCA Pharmaceutical Business Overview
  106. 7.18.3 BBCA Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  107. 7.18.4 BBCA Pharmaceutical Intravenous Nutritional Product Product Portfolio
  108. 7.18.5 BBCA Pharmaceutical Recent Developments
  109. 7.19 Baizheng Pharmaceutical
  110. 7.19.1 Baizheng Pharmaceutical Company Information
  111. 7.19.2 Baizheng Pharmaceutical Business Overview
  112. 7.19.3 Baizheng Pharmaceutical Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Baizheng Pharmaceutical Intravenous Nutritional Product Product Portfolio
  114. 7.19.5 Baizheng Pharmaceutical Recent Developments
  115. 7.20 Aguettant
  116. 7.20.1 Aguettant Company Information
  117. 7.20.2 Aguettant Business Overview
  118. 7.20.3 Aguettant Intravenous Nutritional Product Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Aguettant Intravenous Nutritional Product Product Portfolio
  120. 7.20.5 Aguettant Recent Developments
8 North America
  1. 8.1 North America Intravenous Nutritional Product Revenue (2021-2032)
  2. 8.2 North America Intravenous Nutritional Product Revenue by Type (2021-2032)
  3. 8.2.1 North America Intravenous Nutritional Product Revenue by Type (2021-2026)
  4. 8.2.2 North America Intravenous Nutritional Product Revenue by Type (2027-2032)
  5. 8.3 North America Intravenous Nutritional Product Revenue Share by Type (2021-2032)
  6. 8.4 North America Intravenous Nutritional Product Revenue by Application (2021-2032)
  7. 8.4.1 North America Intravenous Nutritional Product Revenue by Application (2021-2026)
  8. 8.4.2 North America Intravenous Nutritional Product Revenue by Application (2027-2032)
  9. 8.5 North America Intravenous Nutritional Product Revenue Share by Application (2021-2032)
  10. 8.6 North America Intravenous Nutritional Product Revenue by Country
  11. 8.6.1 North America Intravenous Nutritional Product Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Intravenous Nutritional Product Revenue by Country (2021-2026)
  13. 8.6.3 North America Intravenous Nutritional Product Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Intravenous Nutritional Product Revenue (2021-2032)
  2. 9.2 Europe Intravenous Nutritional Product Revenue by Type (2021-2032)
  3. 9.2.1 Europe Intravenous Nutritional Product Revenue by Type (2021-2026)
  4. 9.2.2 Europe Intravenous Nutritional Product Revenue by Type (2027-2032)
  5. 9.3 Europe Intravenous Nutritional Product Revenue Share by Type (2021-2032)
  6. 9.4 Europe Intravenous Nutritional Product Revenue by Application (2021-2032)
  7. 9.4.1 Europe Intravenous Nutritional Product Revenue by Application (2021-2026)
  8. 9.4.2 Europe Intravenous Nutritional Product Revenue by Application (2027-2032)
  9. 9.5 Europe Intravenous Nutritional Product Revenue Share by Application (2021-2032)
  10. 9.6 Europe Intravenous Nutritional Product Revenue by Country
  11. 9.6.1 Europe Intravenous Nutritional Product Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Intravenous Nutritional Product Revenue by Country (2021-2026)
  13. 9.6.3 Europe Intravenous Nutritional Product Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Intravenous Nutritional Product Revenue (2021-2032)
  2. 10.2 China Intravenous Nutritional Product Revenue by Type (2021-2032)
  3. 10.2.1 China Intravenous Nutritional Product Revenue by Type (2021-2026)
  4. 10.2.2 China Intravenous Nutritional Product Revenue by Type (2027-2032)
  5. 10.3 China Intravenous Nutritional Product Revenue Share by Type (2021-2032)
  6. 10.4 China Intravenous Nutritional Product Revenue by Application (2021-2032)
  7. 10.4.1 China Intravenous Nutritional Product Revenue by Application (2021-2026)
  8. 10.4.2 China Intravenous Nutritional Product Revenue by Application (2027-2032)
  9. 10.5 China Intravenous Nutritional Product Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Intravenous Nutritional Product Revenue (2021-2032)
  2. 11.2 Asia Intravenous Nutritional Product Revenue by Type (2021-2032)
  3. 11.2.1 Asia Intravenous Nutritional Product Revenue by Type (2021-2026)
  4. 11.2.2 Asia Intravenous Nutritional Product Revenue by Type (2027-2032)
  5. 11.3 Asia Intravenous Nutritional Product Revenue Share by Type (2021-2032)
  6. 11.4 Asia Intravenous Nutritional Product Revenue by Application (2021-2032)
  7. 11.4.1 Asia Intravenous Nutritional Product Revenue by Application (2021-2026)
  8. 11.4.2 Asia Intravenous Nutritional Product Revenue by Application (2027-2032)
  9. 11.5 Asia Intravenous Nutritional Product Revenue Share by Application (2021-2032)
  10. 11.6 Asia Intravenous Nutritional Product Revenue by Country
  11. 11.6.1 Asia Intravenous Nutritional Product Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Intravenous Nutritional Product Revenue by Country (2021-2026)
  13. 11.6.3 Asia Intravenous Nutritional Product Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Intravenous Nutritional Product Revenue (2021-2032)
  2. 12.2 SAMEA Intravenous Nutritional Product Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Intravenous Nutritional Product Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Intravenous Nutritional Product Revenue by Type (2027-2032)
  5. 12.3 SAMEA Intravenous Nutritional Product Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Intravenous Nutritional Product Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Intravenous Nutritional Product Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Intravenous Nutritional Product Revenue by Application (2027-2032)
  9. 12.5 SAMEA Intravenous Nutritional Product Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Intravenous Nutritional Product Revenue by Country
  11. 12.6.1 SAMEA Intravenous Nutritional Product Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Intravenous Nutritional Product Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Intravenous Nutritional Product Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst